MOUNTAIN VIEW, Calif., June 21 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has been invited to present at the Jefferies Life Sciences Conference, which will take place at the Mandarin Oriental Hotel in New York City. The Company is scheduled to present its business strategy and historical financial performance on Wednesday, June 28, 2006 at 3:30 p.m. Eastern Time. The presentation will be made by IRIDEX President and CEO, Barry G. Caldwell. Following the formal presentation, Mr. Caldwell and the Company's Senior Vice President and CFO, Larry Tannenbaum, will be available for a question and answer session.
Attendance at the conference is by invitation only. IRIDEX will offer a live audio webcast of its presentation which may be accessed at the Company's website at www.iridex.com. An archived replay of the presentation will be available following the live presentation and will also be available at www.iridex.com.
About IRIDEX
IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin diseases in dermatology markets (also referred to as aesthetics). IRIDEX products are sold in the United States through a direct sales force and internationally through a network of 77 independent distributors into 107 countries. For further information, visit the Company's website at www.iridex.com.
SOURCE IRIDEX Corporation
06/21/2006
CONTACT: Larry Tannenbaum, Chief Financial Officer of IRIDEX
Corporation, +1-650-940-4700
/Web site: http://www.iridex.com
(IRIX)
